STAAR Surgical Company (STAA)
USD 24.26
(-4.64%)
USD 24.26
(-4.64%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 224.55 Million USD | 25.04% |
| 2022 | 179.58 Million USD | 23.59% |
| 2021 | 145.29 Million USD | 30.2% |
| 2020 | 111.59 Million USD | 11.48% |
| 2019 | 100.1 Million USD | 17.88% |
| 2018 | 84.91 Million USD | 25.04% |
| 2017 | 67.91 Million USD | -4.38% |
| 2016 | 71.02 Million USD | 22.33% |
| 2015 | 58.06 Million USD | 2.13% |
| 2014 | 56.85 Million USD | 14.6% |
| 2013 | 49.6 Million USD | 9.0% |
| 2012 | 45.51 Million USD | 14.97% |
| 2011 | 39.58 Million USD | 5.06% |
| 2010 | 37.67 Million USD | -17.41% |
| 2009 | 45.62 Million USD | -24.58% |
| 2008 | 60.49 Million USD | 39.44% |
| 2007 | 43.38 Million USD | 8.37% |
| 2006 | 40.03 Million USD | 15.71% |
| 2005 | 34.59 Million USD | -4.69% |
| 2004 | 36.3 Million USD | 5.64% |
| 2003 | 34.36 Million USD | 9.92% |
| 2002 | 31.26 Million USD | -4.07% |
| 2001 | 32.58 Million USD | -36.8% |
| 2000 | 51.56 Million USD | 42.06% |
| 1999 | 36.3 Million USD | 8.36% |
| 1998 | 33.5 Million USD | 26.89% |
| 1997 | 26.4 Million USD | 9.09% |
| 1996 | 24.2 Million USD | 16.91% |
| 1995 | 20.7 Million USD | 21.05% |
| 1994 | 17.1 Million USD | 13.25% |
| 1993 | 15.1 Million USD | 21.77% |
| 1992 | 12.4 Million USD | -8.15% |
| 1991 | 13.5 Million USD | 104.55% |
| 1990 | 6.6 Million USD | 633.33% |
| 1989 | 900 Thousand USD | -40.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 63.31 Million USD | 25.83% |
| 2024 Q2 | 66.51 Million USD | 5.05% |
| 2024 Q3 | 77.3 Million USD | -5.58% |
| 2023 Q3 | 57.34 Million USD | -7.7% |
| 2023 FY | 224.55 Million USD | 25.04% |
| 2023 Q4 | 50.32 Million USD | -12.25% |
| 2023 Q1 | 54.76 Million USD | 12.17% |
| 2023 Q2 | 62.12 Million USD | 13.45% |
| 2022 Q3 | 46.75 Million USD | -0.2% |
| 2022 FY | 179.58 Million USD | 23.59% |
| 2022 Q1 | 37.15 Million USD | -1.22% |
| 2022 Q2 | 46.85 Million USD | 26.11% |
| 2022 Q4 | 48.82 Million USD | 4.41% |
| 2021 Q1 | 31.67 Million USD | 4.79% |
| 2021 Q2 | 38.55 Million USD | 21.73% |
| 2021 FY | 145.29 Million USD | 30.2% |
| 2021 Q3 | 37.46 Million USD | -2.83% |
| 2021 Q4 | 37.6 Million USD | 0.38% |
| 2020 FY | 111.59 Million USD | 11.48% |
| 2020 Q2 | 25.48 Million USD | -1.58% |
| 2020 Q3 | 29.98 Million USD | 17.67% |
| 2020 Q4 | 30.22 Million USD | 0.78% |
| 2020 Q1 | 25.89 Million USD | -2.22% |
| 2019 Q2 | 25.28 Million USD | 11.82% |
| 2019 Q1 | 22.61 Million USD | 3.71% |
| 2019 FY | 100.1 Million USD | 17.88% |
| 2019 Q4 | 26.48 Million USD | 2.97% |
| 2019 Q3 | 25.71 Million USD | 1.7% |
| 2018 Q4 | 21.8 Million USD | -2.12% |
| 2018 Q2 | 22.2 Million USD | 19.16% |
| 2018 Q1 | 18.63 Million USD | -0.04% |
| 2018 FY | 84.91 Million USD | 25.04% |
| 2018 Q3 | 22.27 Million USD | 0.34% |
| 2017 FY | 67.91 Million USD | -4.38% |
| 2017 Q4 | 18.64 Million USD | 17.93% |
| 2017 Q3 | 15.8 Million USD | -5.88% |
| 2017 Q2 | 16.79 Million USD | 0.73% |
| 2017 Q1 | 16.67 Million USD | 14.03% |
| 2016 Q4 | 14.62 Million USD | -11.85% |
| 2016 Q1 | 23.04 Million USD | 56.48% |
| 2016 Q2 | 16.76 Million USD | -27.24% |
| 2016 FY | 71.02 Million USD | 22.33% |
| 2016 Q3 | 16.58 Million USD | -1.08% |
| 2015 Q1 | 14.4 Million USD | 9.62% |
| 2015 Q3 | 14.82 Million USD | 5.08% |
| 2015 FY | 58.06 Million USD | 2.13% |
| 2015 Q4 | 14.72 Million USD | -0.63% |
| 2015 Q2 | 14.1 Million USD | -2.12% |
| 2014 Q3 | 13.42 Million USD | -10.86% |
| 2014 Q1 | 15.22 Million USD | 7.02% |
| 2014 Q2 | 15.05 Million USD | -1.11% |
| 2014 FY | 56.85 Million USD | 14.6% |
| 2014 Q4 | 13.14 Million USD | -2.06% |
| 2013 Q4 | 14.22 Million USD | 19.7% |
| 2013 FY | 49.6 Million USD | 9.0% |
| 2013 Q1 | 11.57 Million USD | -6.78% |
| 2013 Q2 | 11.92 Million USD | 3.08% |
| 2013 Q3 | 11.88 Million USD | -0.34% |
| 2012 Q2 | 11.2 Million USD | 5.51% |
| 2012 Q1 | 10.62 Million USD | -1.27% |
| 2012 Q4 | 12.41 Million USD | 10.15% |
| 2012 Q3 | 11.26 Million USD | 0.52% |
| 2012 FY | 45.51 Million USD | 14.97% |
| 2011 FY | 39.58 Million USD | 5.06% |
| 2011 Q3 | 9.71 Million USD | 0.23% |
| 2011 Q2 | 9.69 Million USD | 2.87% |
| 2011 Q4 | 10.76 Million USD | 10.79% |
| 2011 Q1 | 9.42 Million USD | -5.75% |
| 2010 Q2 | 9.47 Million USD | 8.28% |
| 2010 FY | 37.67 Million USD | -17.41% |
| 2010 Q4 | 9.99 Million USD | 5.76% |
| 2010 Q3 | 9.45 Million USD | -0.27% |
| 2010 Q1 | 8.75 Million USD | -25.93% |
| 2009 Q1 | 11.47 Million USD | -38.35% |
| 2009 FY | 45.62 Million USD | -24.58% |
| 2009 Q4 | 11.81 Million USD | 7.39% |
| 2009 Q3 | 11 Million USD | -2.86% |
| 2009 Q2 | 11.32 Million USD | -1.26% |
| 2008 FY | 60.49 Million USD | 39.44% |
| 2008 Q1 | 16.47 Million USD | 42.11% |
| 2008 Q2 | 13.52 Million USD | -17.92% |
| 2008 Q3 | 11.88 Million USD | -12.12% |
| 2008 Q4 | 18.61 Million USD | 56.61% |
| 2007 FY | 43.38 Million USD | 8.37% |
| 2007 Q1 | 10.49 Million USD | -6.69% |
| 2007 Q2 | 10.9 Million USD | 3.94% |
| 2007 Q3 | 10.38 Million USD | -4.79% |
| 2007 Q4 | 11.59 Million USD | 11.63% |
| 2006 Q4 | 11.24 Million USD | 23.67% |
| 2006 FY | 40.03 Million USD | 15.71% |
| 2006 Q3 | 9.09 Million USD | -9.8% |
| 2006 Q1 | 9.6 Million USD | 6.21% |
| 2006 Q2 | 10.08 Million USD | 4.93% |
| 2005 Q4 | 9.04 Million USD | 6.12% |
| 2005 FY | 34.59 Million USD | -4.69% |
| 2005 Q2 | 8.54 Million USD | 0.65% |
| 2005 Q3 | 8.52 Million USD | -0.18% |
| 2005 Q1 | 8.48 Million USD | -18.4% |
| 2004 Q2 | 9.42 Million USD | 13.69% |
| 2004 Q4 | 10.39 Million USD | 27.01% |
| 2004 Q1 | 8.29 Million USD | -14.0% |
| 2004 FY | 36.3 Million USD | 5.64% |
| 2004 Q3 | 8.18 Million USD | -13.14% |
| 2003 Q2 | 8.01 Million USD | 5.1% |
| 2003 FY | 34.36 Million USD | 9.92% |
| 2003 Q1 | 7.62 Million USD | 2.14% |
| 2003 Q3 | 9.08 Million USD | 13.38% |
| 2003 Q4 | 9.64 Million USD | 6.11% |
| 2002 Q3 | 7.31 Million USD | -18.69% |
| 2002 Q1 | 7.48 Million USD | -7.63% |
| 2002 Q2 | 9 Million USD | 20.32% |
| 2002 FY | 31.26 Million USD | -4.07% |
| 2002 Q4 | 7.46 Million USD | 2.0% |
| 2001 Q3 | 7.44 Million USD | -16.17% |
| 2001 Q1 | 8.16 Million USD | -64.78% |
| 2001 Q2 | 8.87 Million USD | 8.7% |
| 2001 FY | 32.58 Million USD | -36.8% |
| 2001 Q4 | 8.09 Million USD | 8.8% |
| 2000 Q3 | 8.24 Million USD | -22.12% |
| 2000 Q4 | 23.19 Million USD | 181.21% |
| 2000 FY | 51.56 Million USD | 42.06% |
| 2000 Q2 | 10.58 Million USD | 10.96% |
| 2000 Q1 | 9.54 Million USD | -11.64% |
| 1999 Q3 | 8.3 Million USD | -3.49% |
| 1999 FY | 36.3 Million USD | 8.36% |
| 1999 Q4 | 10.8 Million USD | 30.12% |
| 1999 Q2 | 8.6 Million USD | -1.15% |
| 1999 Q1 | 8.7 Million USD | 2.35% |
| 1998 Q1 | 8.4 Million USD | 21.74% |
| 1998 FY | 33.5 Million USD | 26.89% |
| 1998 Q4 | 8.5 Million USD | 3.66% |
| 1998 Q3 | 8.2 Million USD | -3.53% |
| 1998 Q2 | 8.5 Million USD | 1.19% |
| 1997 Q3 | 6.6 Million USD | -4.35% |
| 1997 Q4 | 6.9 Million USD | 4.55% |
| 1997 Q2 | 6.9 Million USD | 15.0% |
| 1997 FY | 26.4 Million USD | 9.09% |
| 1997 Q1 | 6 Million USD | -6.25% |
| 1996 FY | 24.2 Million USD | 16.91% |
| 1996 Q4 | 6.4 Million USD | 10.34% |
| 1996 Q3 | 5.8 Million USD | -6.45% |
| 1996 Q2 | 6.2 Million USD | 5.08% |
| 1996 Q1 | 5.9 Million USD | -4.84% |
| 1995 Q2 | 5.1 Million USD | 15.91% |
| 1995 FY | 20.7 Million USD | 21.05% |
| 1995 Q4 | 6.2 Million USD | 26.53% |
| 1995 Q3 | 4.9 Million USD | -3.92% |
| 1995 Q1 | 4.4 Million USD | -12.0% |
| 1994 FY | 17.1 Million USD | 13.25% |
| 1994 Q1 | 3.9 Million USD | -18.75% |
| 1994 Q2 | 4.2 Million USD | 7.69% |
| 1994 Q3 | 4 Million USD | -4.76% |
| 1994 Q4 | 5 Million USD | 25.0% |
| 1993 Q3 | 3.4 Million USD | -10.53% |
| 1993 Q4 | 4.8 Million USD | 41.18% |
| 1993 Q2 | 3.8 Million USD | 0.0% |
| 1993 Q1 | - USD | 100.0% |
| 1993 FY | 15.1 Million USD | 21.77% |
| 1992 Q1 | - USD | 100.0% |
| 1992 Q4 | -14.8 Million USD | 0.0% |
| 1992 FY | 12.4 Million USD | -8.15% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q4 | -15.5 Million USD | 0.0% |
| 1991 Q1 | 1.8 Million USD | 120.93% |
| 1991 Q2 | - USD | -100.0% |
| 1991 FY | 13.5 Million USD | 104.55% |
| 1991 Q3 | - USD | 0.0% |
| 1990 FY | 6.6 Million USD | 633.33% |
| 1990 Q1 | - USD | 100.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | -8.6 Million USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1989 Q4 | -8.1 Million USD | 0.0% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | 900 Thousand USD | -40.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | -115.358% |
| AngioDynamics, Inc. | 252.41 Million USD | 11.038% |
| AtriCure, Inc. | 327.05 Million USD | 31.34% |
| Avinger, Inc. | 18.63 Million USD | -1104.818% |
| Azenta, Inc. | 336.26 Million USD | 33.221% |
| BioLife Solutions, Inc. | 117.57 Million USD | -90.985% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 87.694% |
| Daxor Corporation | 1.28 Million USD | -17436.226% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -828.254% |
| Femasys Inc. | 15.2 Million USD | -1377.298% |
| GlucoTrack, Inc. | 7.1 Million USD | -3060.952% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -283.322% |
| Hologic, Inc. | 1.34 Billion USD | 83.307% |
| ICU Medical, Inc. | 717.04 Million USD | 68.684% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 92.421% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -760.101% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | -148.574% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 188280.576% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 188280.576% |
| Masimo Corporation | 867 Million USD | 74.1% |
| Microbot Medical Inc. | 9.85 Million USD | -2178.579% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -1119.073% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 51.176% |
| Nephros, Inc. | 9.78 Million USD | -2195.114% |
| NovoCure Limited | 613.92 Million USD | 63.423% |
| NEXGEL, Inc. | 4.09 Million USD | -5382.275% |
| NEXGEL, Inc. | 4.09 Million USD | -5382.275% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | -119.628% |
| OraSure Technologies, Inc. | 125.34 Million USD | -79.153% |
| Pro-Dex, Inc. | 7.37 Million USD | -2943.562% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -415.339% |
| Predictive Oncology Inc. | 15.22 Million USD | -1374.464% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -2534.958% |
| QuidelOrtho Corporation | 1.35 Billion USD | 83.431% |
| Repligen Corporation | 261.12 Million USD | 14.005% |
| Sanara MedTech Inc. | 61.12 Million USD | -267.355% |
| Sharps Technology, Inc. | 10.12 Million USD | -2117.456% |
| Utah Medical Products, Inc. | 13.26 Million USD | -1593.341% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 87.483% |
| Jin Medical International Ltd. | 3.91 Million USD | -5631.969% |